No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
243 |
4. Check minimum number of eventsNone |
243 |
5. Include endpointsNone |
243 |
6. Filter based on genotype QC (FinnGen only) |
240 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ovary, including Hilmo
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 240 | 240 | - |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | - |
| Median age at first event (years) | 54.44 | 54.44 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 243
- Matched controls
- 2430
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
286.7
215
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
57.3
155.7
93
26
H02AB02
ATC
dexamethasone; systemic
89.6
147.0
79
13
JEA00
NOMESCO Finland
Appendectomy
24.9
116.8
95
61
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
115.0
101
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
31.6
102.6
72
32
128
Kela drug reimbursment
Cancers of female genital organs
+∞
95.2
85
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
25.2
93.5
72
40
WX302
NOMESCO Finland
Thoracal epidural anesthesy
37.6
92.3
60
21
A04AA01
ATC
ondansetron; systemic, rectal
31.0
87.7
61
26
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
78.5
71
*
JAL30
NOMESCO Finland
Omentectomy
165.9
78.4
79
7
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
77.3
70
*
JN4BD
NOMESCO Finland
Extensive body CT
19.1
69.8
60
41
LCD00
NOMESCO Finland
Hysterectomy
13.2
68.0
76
81
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
63.3
58
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
17.6
59.8
53
38
A03FA01
ATC
metoclopramide; systemic, rectal
8.1
58.5
115
242
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
50.8
47
*
B01AB10
ATC
tinzaparin; parenteral
8.5
46.1
72
115
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.1
44.3
63
90
121
Kela drug reimbursment
Severe hypofunction of sexual glands
20.3
43.7
35
20
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
41.9
39
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
40.8
38
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
34.2
32
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.5
32.5
82
206
A04AA02
ATC
granisetron; systemic, transdermal
356.3
31.6
31
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
342.7
30.5
30
*
L03AA13
ATC
pegfilgrastim; parenteral
342.7
30.5
30
*
JN4AD
NOMESCO Finland
Body CT examination
8.9
30.3
41
54
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.2
27.2
143
617
Z51.5
ICD-10 Finland
Palliative care
11.3
27.0
30
30
JAL00
NOMESCO Finland
Biopsy of peritoneum
68.0
26.6
30
5
130
Kela drug reimbursment
Malignant tumour
+∞
26.5
25
*
B01AB05
ATC
enoxaparin; parenteral
4.1
26.3
127
513
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
26.1
26.1
36
16
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
5.0
25.7
68
175
Z31.5
ICD-10 Finland
Genetic counselling
8.6
24.9
34
45
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
24.4
23
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
23.3
22
*
L03AA02
ATC
filgrastim; parenteral
+∞
23.3
22
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
22.2
21
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
228.8
20.9
21
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
20.1
19
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
20.1
19
*
HA1AA
NOMESCO Finland
X-ray mammography
7.3
19.2
30
46
A04AA03
ATC
tropisetron; systemic
205.2
18.8
19
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.1
18.7
44
101
R18
ICD-10 Finland
Ascites
29.4
18.2
24
9
115
Kela drug reimbursment
Breast cancer
+∞
17.9
17
*
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
18.8
17.9
27
16
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.9
16
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.4
16.6
47
125
ZX120
NOMESCO Finland
Intravenous
6.0
16.4
31
58
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
15.8
15
*
L02BG04
ATC
letrozole; oral
19.4
15.5
23
13
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
6.2
15.0
27
48
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
14.7
14
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
159.2
14.6
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.1
14.4
27
27
JAH01
NOMESCO Finland
Laparoscopy
5.8
14.1
27
51
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
79.7
13.7
15
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
13.7
13
*
X77
ICPC
Malignant neopl genital female other
+∞
13.7
13
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
13.7
13
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.7
13
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
13.7
13
*
N02AA05
ATC
oxycodone; systemic
3.3
12.9
57
205
WX402
NOMESCO Finland
General anaesthesia
3.1
12.7
64
248
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
12.6
12
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
12.6
12
*
C567, ,
ICD-10 Finland
+∞
12.6
12
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
15.4
12.5
20
14
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.6
12.1
21
18
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.5
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
125.7
11.5
12
*
WW500
NOMESCO Finland
Blood transfusion
13.6
11.3
19
15
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
12.0
11.3
20
18
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.1
11.1
53
198
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
45.5
11.0
13
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
62.8
10.7
12
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
114.8
10.5
11
*
L02BA01
ATC
tamoxifen; oral
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
10.2
89
455
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
10.0
44
156
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
12.1
9.7
17
15
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
12.1
9.7
17
15
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
103.9
9.5
10
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
9.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
A79
ICPC
Malignancy NOS
+∞
9.4
9
*
JAH00
NOMESCO Finland
Laparotomy
9.6
9.2
18
20
HAB40
NOMESCO Finland
Wedge excision of mammary gland
38.2
9.1
11
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.8
9.0
21
47
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
17.1
8.6
13
8
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
8.6
105
613
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
28.7
8.6
11
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.5
8.4
19
27
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
8.4
8
*
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
R2110
NOMESCO Finland
Giving the first information
3.5
8.3
30
94
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
7.8
60
284
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
46.5
7.8
9
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
7.4
39
153
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
7.3
7
*
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
+∞
7.3
7
*
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
+∞
7.3
7
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
23.3
6.7
9
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
12.7
6.6
11
9
JN4CD
NOMESCO Finland
Very extensive body CT
12.7
6.6
11
9
Z3231
NOMESCO Finland
Registered nurse
2.2
6.6
74
409
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
2.4
6.5
48
223
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
71.7
6.5
7
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
14.8
6.5
10
7
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
6.3
6
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.2
111
726
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
13.0
6.1
10
8
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
13.0
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
87
96
13.56
76.60
2.7
1.4
12.77
2.71
ug/l
1.49
70
73
24
45
5.81
12.57
3.0
1.6
516.84
14.53
u/ml
0.56
19
40
16
7
24.33
11.73
1.1
1.6
—
—
—
0
0
80
423
2.33
8.21
2.3
1.8
—
—
—
0
0
132
868
2.14
7.78
2.8
2.2
—
—
—
0
0
43
178
2.72
7.36
9.0
5.4
0.89
1.87
mmol/l
0.94
36
149
119
818
1.89
5.58
4.6
3.2
34.82
36.13
g/l
1.46
113
751
23
84
2.92
4.93
12.8
5.2
24.97
25.79
mmol/l
0.40
23
84
120
855
1.80
4.79
6.7
4.5
1.21
1.23
mmol/l
1.99
107
766
37
183
2.21
4.27
10.0
4.5
104.73
104.36
mmol/l
0.17
37
183
127
956
1.69
3.92
7.4
4.9
1.20
1.23
mmol/l
3.20
108
828
45
249
1.99
3.88
2.4
1.5
29.00
29.14
s
0.06
45
242
114
840
1.67
3.77
13.6
11.6
1.30
1.22
inr
0.40
33
252
136
1068
1.62
3.37
14.4
6.1
4.01
4.17
e9/l
0.36
110
925
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
34
3.66
3.24
2.8
2.9
0.30
0.40
u/ml
—
6
23
21
92
2.40
3.20
12.9
6.2
0.56
0.72
%
1.06
21
92
21
92
2.40
3.20
12.6
6.2
1.19
1.42
%
0.70
21
92
47
282
1.83
3.17
1.6
1.7
—
—
—
0
0
216
2297
0.46
3.16
27.3
16.9
4.32
4.43
e12/l
3.11
207
2230
216
2296
0.47
3.10
27.3
16.9
271.40
262.08
e9/l
1.01
210
2238
216
2295
0.47
3.05
28.1
16.8
38.42
39.66
%
2.22
198
2145
190
2096
0.57
3.03
4.1
4.6
5.92
5.86
mmol/l
0.30
164
1920
35
194
1.94
3.00
1.5
1.7
—
—
—
0
0
35
196
1.92
2.91
1.5
1.7
—
—
—
0
0
138
1126
1.52
2.63
6.4
3.7
6.64
6.60
mmol/l
0.08
128
1026
185
2041
0.61
2.63
6.0
5.3
1.87
2.44
mu/l
0.47
167
1879
175
1954
0.63
2.59
5.4
5.8
39.79
39.57
mmol/mol
0.11
157
1816
197
2135
0.59
2.46
4.3
5.1
2.82
2.85
mmol/l
0.14
175
1972
120
965
1.48
2.37
8.2
3.2
9.18
10.37
umol/l
2.03
114
900
8
24
3.41
2.20
1.1
1.2
—
—
—
0
0
7
20
3.57
2.07
1.1
1.3
—
—
—
0
0
86
665
1.45
2.00
3.9
1.9
2.37
2.36
mmol/l
0.45
73
559
194
2093
0.64
1.99
3.9
4.5
4.82
4.86
mmol/l
0.22
176
1941
42
279
1.61
1.97
3.5
2.7
3.80
3.96
e6/l
0.04
23
130
6
16
3.82
1.94
1.2
1.1
—
—
—
0
0
6
17
3.59
1.85
1.2
1.3
—
—
—
0
0
8
29
2.82
1.81
1.0
1.2
—
—
—
0
0
22
125
1.84
1.79
1.6
1.6
—
—
—
0
0
44
305
1.54
1.73
3.1
2.5
1.10
1.30
e6/l
0.24
24
156
209
2207
0.62
1.68
13.7
8.6
23.07
23.13
u/l
0.02
199
2119
7
25
2.85
1.66
1.4
1.2
—
—
—
0
0
7
25
2.85
1.66
1.6
1.2
—
—
—
0
0
194
2078
0.67
1.63
3.8
4.5
1.55
1.60
mmol/l
1.04
173
1919
5
14
3.62
1.62
1.0
1.0
—
—
—
0
0
169
1508
1.40
1.59
8.6
5.0
78.17
75.77
u/l
0.41
154
1386
208
2193
0.64
1.53
22.8
12.8
68.55
69.52
umol/l
0.31
208
2193
27
402
0.63
1.46
1.5
1.5
—
—
—
0
0
37
510
0.68
1.38
1.3
1.3
1.44
2.30
u/ml
0.37
14
143
5
17
2.98
1.36
1.2
1.5
64.80
67.94
umol/l
—
5
17
6
24
2.54
1.31
1.8
1.2
—
—
—
0
0
8
35
2.33
1.28
1.6
1.2
—
—
—
0
0
187
1997
0.72
1.26
3.4
4.0
1.33
1.24
mmol/l
1.02
159
1821
8
37
2.20
1.22
1.1
1.2
—
—
—
0
0
8
37
2.20
1.22
1.1
1.2
—
—
—
0
0
5
19
2.66
1.22
2.0
1.3
—
—
—
0
0
57
446
1.36
1.20
2.1
1.7
1.32
0.95
mg/l
1.03
51
346
116
1316
0.77
1.19
2.4
3.1
—
—
—
0
0
11
196
0.54
1.18
1.8
1.9
—
—
—
0
0
15
88
1.75
1.14
2.7
2.0
0.91
1.10
%
0.39
15
88
79
936
0.77
1.12
2.0
2.3
75.98
79.55
nmol/l
0.51
66
832
8
41
1.98
1.10
1.6
1.2
—
—
—
0
0
63
509
1.32
1.07
4.4
2.9
0.28
0.52
e6/l
0.91
48
377
16
98
1.68
1.06
1.4
1.6
—
—
—
0
0
81
949
0.78
1.03
2.6
2.7
99.20
83.05
ug/l
0.51
70
876
5
23
2.20
0.98
1.2
1.2
—
—
—
0
0
14
87
1.65
0.89
2.9
2.0
0.60
0.68
%
0.84
14
87
8
42
1.94
0.89
3.0
2.5
—
—
—
0
0
186
1962
0.78
0.86
18.3
10.2
82.06
79.78
ml/min/173m2
0.71
153
1570
10
57
1.79
0.85
1.2
1.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
85.40
—
0
5
8
48
1.69
0.79
1.4
1.4
—
—
—
0
0
72
615
1.24
0.79
4.8
2.4
29.15
28.64
u/l
0.07
67
587
20
277
0.70
0.79
3.9
4.5
32.56
33.25
%
—
9
173
117
1056
1.21
0.74
4.7
3.8
0.00
0.02
estimate
0.50
23
188
7
39
1.82
0.73
1.1
1.3
—
—
—
0
0
15
216
0.67
0.73
1.9
2.0
—
—
—
0
0
7
43
1.65
0.67
1.1
1.1
—
—
—
0
0
72
627
1.21
0.65
3.2
2.0
51.73
56.79
u/l
0.39
64
578
5
29
1.74
0.64
5.2
2.1
103.00
106.14
mmol/l
—
5
29
148
1579
0.84
0.64
4.2
4.3
16.72
11.86
mm/h
2.20
137
1437
6
101
0.58
0.63
5.7
3.4
2.52
1.99
mmol/l
—
6
76
6
104
0.57
0.63
1.2
1.5
—
—
—
0
0
115
1049
1.18
0.62
7.0
5.2
0.00
0.00
estimate
-0.00
21
181
207
2137
0.79
0.60
21.6
13.2
3.92
3.94
mmol/l
0.56
201
2072
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
5
87
0.57
0.57
1.4
1.4
—
—
—
0
0
8
55
1.47
0.56
1.9
1.5
—
0.34
—
0
7
75
667
1.18
0.54
4.3
2.9
—
—
—
0
0
20
154
1.33
0.50
5.3
1.4
65.51
67.96
g/l
1.41
20
140
7
110
0.63
0.49
1.3
1.5
—
—
—
0
0
81
890
0.87
0.46
2.0
2.0
95.58
98.94
pmol/l
0.23
42
412
170
1769
0.87
0.42
5.2
4.4
15.20
14.72
pmol/l
1.69
156
1621
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
10
137
0.72
0.40
1.9
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
2.0
—
—
—
0
0
55
490
1.16
0.39
3.2
1.9
9209.08
5190.03
umol/l
0.18
50
419
45
510
0.86
0.39
1.5
1.5
19.28
22.40
nmol/l
0.76
38
434
173
1794
0.88
0.38
23.0
13.3
14.52
15.01
%
0.76
168
1761
8
114
0.69
0.38
1.0
1.1
—
—
—
0
0
10
72
1.41
0.37
1.7
1.7
—
—
—
0
0
36
414
0.85
0.37
1.7
1.7
1115.89
1162.99
nmol/l
0.08
18
305
11
81
1.38
0.37
1.3
1.5
—
—
—
0
0
21
172
1.24
0.35
1.2
1.2
192.70
132.29
iu/ml
—
8
71
6
87
0.68
0.33
1.3
2.0
—
—
—
0
0
19
155
1.24
0.33
2.8
1.7
57.67
69.84
ml/min/173m2
—
6
62
6
89
0.67
0.33
1.5
1.7
—
—
—
0
0
6
47
1.28
0.32
1.2
1.2
—
—
—
0
0
201
2057
0.87
0.32
17.0
11.3
30.02
19.08
mg/l
4.16
174
1557
10
75
1.35
0.30
1.9
1.7
—
—
—
0
0
110
1040
1.11
0.30
4.8
3.8
0.00
0.00
estimate
-0.00
23
202
22
187
1.19
0.27
4.5
3.1
—
—
—
0
0
53
484
1.12
0.27
1.4
1.4
—
—
—
0
0
5
74
0.67
0.26
9.0
1.3
2.94
3.78
g/l
—
5
68
5
74
0.67
0.26
9.0
1.3
—
—
—
0
0
5
74
0.67
0.26
9.0
1.3
7.74
7.68
g/l
—
5
68
33
367
0.88
0.23
4.4
4.0
119.64
239.14
ng/l
0.28
28
279
5
40
1.26
0.22
1.8
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
77
814
0.92
0.21
5.0
3.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
4.68
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.07
—
0
7
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
6
52
1.16
0.19
1.7
1.4
—
—
—
0
0
40
433
0.91
0.18
1.3
1.3
46.88
37.83
iu/ml
—
10
151
5
70
0.71
0.17
9.0
1.3
6.96
10.21
g/l
—
5
64
60
631
0.93
0.14
3.5
3.6
9.50
4.99
mg/mmol
0.53
35
360
73
762
0.94
0.14
3.9
3.5
18.93
69.62
ng/l
0.53
51
500
12
103
1.17
0.14
1.3
1.6
—
—
—
0
0
57
542
1.07
0.13
3.3
2.8
1229.27
1069.71
ng/l
0.13
47
440
135
1322
1.05
0.11
3.4
2.8
43.63
37.88
u/l
0.42
119
1229
52
544
0.94
0.10
4.9
4.1
0.00
0.00
estimate
-0.00
18
187
5
62
0.80
0.08
1.0
1.7
—
—
—
0
0
7
83
0.84
0.07
1.1
1.3
—
23.70
—
0
6
8
93
0.86
0.07
1.0
1.4
—
—
—
0
0
17
181
0.93
0.05
2.2
1.7
—
—
—
0
0
44
450
0.97
0.03
1.4
1.7
453.71
16349231.45
pmol/l
0.50
35
367
43
421
1.03
0.02
1.2
1.3
3.42
11.44
u/ml
1.45
18
161
38
376
1.01
0.00
3.3
2.0
2.49
2.44
mmol/l
1.68
33
323
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
77.60
—
0
5
0
5
0.00
0.00
0.0
1.4
—
454.20
—
0
5
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
95.40
—
0
5
0
5
0.00
0.00
0.0
1.0
—
107.80
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
12.78
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
107.83
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
216.06
—
0
7
26
260
1.00
-0.00
7.0
6.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
57.67
—
0
9
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
208.67
—
0
6
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
66
0.91
-0.00
1.0
1.1
—
9.98
—
0
9
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
79
0.88
-0.00
1.9
2.3
38.00
42.15
u/l
—
7
68
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_MUCINO_WIDE – Mucinous and mucinous cystic tumor, including Hilmo
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).